SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mikey who wrote (770)3/23/1998 12:30:00 AM
From: SKARLOEY  Read Replies (1) of 1055
 
350000 cases a year of prostate cancer alone. at $10000.00/ procedure for thrx...co. rate of growing...their lead over competitors....surgeons and patients looking very favorably at treatment....speculating that thrx could get 50% of biz....were talking $1.75 billion a year, not including other applications being looked at right now. if the stock market is forward looking then it would seem very reasonable that this one could go much higher, even with the present market cap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News